Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-08

Clinical Trial Update: Antialbuminuric Effects of Valsartan and Lisinopril [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the antialbuminuric effects of valsartan and lisinopril in hypertension and early diabetic nephropathy; the study status is term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIOVAN (valsartan)
  • Lisinopril (Lisinopril)

Snippet

Sponsor: Novartis | Conditions: Hypertension, Early Diabetic Nephropathy | Phase 4 | Status: TERMINATED